These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34934510)

  • 1. Angiotensin-converting enzyme 2 as a potential therapeutic target for COVID-19: A review.
    Singh B; Singh D; Verma V; Yadav R; Kumar R
    J Pharm Anal; 2022 Apr; 12(2):215-220. PubMed ID: 34934510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
    Verdecchia P; Reboldi G; Cavallini C; Mazzotta G; Angeli F
    G Ital Cardiol (Rome); 2020 May; 21(5):321-327. PubMed ID: 32310915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of coronaviruses with ACE2, angiotensin II, and RAS inhibitors-lessons from available evidence and insights into COVID-19.
    Kai H; Kai M
    Hypertens Res; 2020 Jul; 43(7):648-654. PubMed ID: 32341442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-angiotensin system inhibitors in management of hypertension during the COVID-19 pandemic.
    Dworakowska D; Grossman AB
    J Physiol Pharmacol; 2020 Apr; 71(2):. PubMed ID: 32633235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges.
    Sriram K; Loomba R; Insel PA
    Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29274-29282. PubMed ID: 33203679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension and COVID-19: Current Evidence and Perspectives.
    Gallo G; Calvez V; Savoia C
    High Blood Press Cardiovasc Prev; 2022 Mar; 29(2):115-123. PubMed ID: 35184271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 infection and smoking: What is the association? A brief review.
    Gupta I; Sohail MU; Elzawawi KE; Amarah AH; Vranic S; Al-Asmakh M; Al Moustafa AE
    Comput Struct Biotechnol J; 2021; 19():1654-1660. PubMed ID: 33777332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin system inhibition in COVID-19 patients.
    de Vries AAF
    Neth Heart J; 2020 Jul; 28(7-8):396-405. PubMed ID: 32514935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE2 in the Era of SARS-CoV-2: Controversies and Novel Perspectives.
    Saponaro F; Rutigliano G; Sestito S; Bandini L; Storti B; Bizzarri R; Zucchi R
    Front Mol Biosci; 2020; 7():588618. PubMed ID: 33195436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
    Kuba K; Yamaguchi T; Penninger JM
    Front Immunol; 2021; 12():732690. PubMed ID: 35003058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin system modulators in COVID-19 patients with hypertension: friend or foe?
    Shylesh C M S; V S A; S K K; P UD
    Clin Exp Hypertens; 2022 Jan; 44(1):1-10. PubMed ID: 34414841
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of ACE inhibitors and angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study.
    Parit R; Jayavel S
    Eur J Pharmacol; 2021 Apr; 896():173899. PubMed ID: 33508281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019.
    Liu MY; Zheng B; Zhang Y; Li JP
    Chronic Dis Transl Med; 2020 Jun; 6(2):98-105. PubMed ID: 32550040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19.
    Kreutz R; Algharably EAE; Azizi M; Dobrowolski P; Guzik T; Januszewicz A; Persu A; Prejbisz A; Riemer TG; Wang JG; Burnier M
    Cardiovasc Res; 2020 Aug; 116(10):1688-1699. PubMed ID: 32293003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment.
    Labandeira-Garcia JL; Labandeira CM; Valenzuela R; Pedrosa MA; Quijano A; Rodriguez-Perez AI
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension.
    Huang Z; Cao J; Yao Y; Jin X; Luo Z; Xue Y; Zhu C; Song Y; Wang Y; Zou Y; Qian J; Yu K; Gong H; Ge J
    Ann Transl Med; 2020 Apr; 8(7):430. PubMed ID: 32395474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE2 as a potential therapeutic target for pandemic COVID-19.
    Chatterjee B; Thakur SS
    RSC Adv; 2020 Oct; 10(65):39808-39813. PubMed ID: 35515386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies.
    Kriszta G; Kriszta Z; Váncsa S; Hegyi PJ; Frim L; Erőss B; Hegyi P; Pethő G; Pintér E
    Front Pharmacol; 2021; 12():619524. PubMed ID: 33762942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II Receptor Blockers (ARBs Antihypertensive Agents) Increase Replication of SARS-CoV-2 in Vero E6 Cells.
    Pires de Souza GA; Osman IO; Le Bideau M; Baudoin JP; Jaafar R; Devaux C; La Scola B
    Front Cell Infect Microbiol; 2021; 11():639177. PubMed ID: 34178717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System.
    Edmonston DL; South AM; Sparks MA; Cohen JB
    Adv Chronic Kidney Dis; 2020 Sep; 27(5):404-411. PubMed ID: 33308506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.